DD237611A5 - Verfahren zur herstellung einer waessrigen ueberzugsmitteldispersion und ihre verwendung zum ueberziehen von arzneimittel - Google Patents

Verfahren zur herstellung einer waessrigen ueberzugsmitteldispersion und ihre verwendung zum ueberziehen von arzneimittel Download PDF

Info

Publication number
DD237611A5
DD237611A5 DD85281842A DD28184285A DD237611A5 DD 237611 A5 DD237611 A5 DD 237611A5 DD 85281842 A DD85281842 A DD 85281842A DD 28184285 A DD28184285 A DD 28184285A DD 237611 A5 DD237611 A5 DD 237611A5
Authority
DD
German Democratic Republic
Prior art keywords
dispersion
copolymer
water
film
weight
Prior art date
Application number
DD85281842A
Other languages
German (de)
English (en)
Inventor
Klaus Lehmann
Dieter Dreher
Wolfgang Weisbrod
Original Assignee
��������@��������@����������@���k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ��������@��������@����������@���k�� filed Critical ��������@��������@����������@���k��
Publication of DD237611A5 publication Critical patent/DD237611A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
    • C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
    • C08J3/05—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media from solid polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2357/00—Characterised by the use of unspecified polymers obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • C08J2357/04—Copolymers in which only the monomer in minority is defined

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Paints Or Removers (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
DD85281842A 1984-10-19 1985-10-17 Verfahren zur herstellung einer waessrigen ueberzugsmitteldispersion und ihre verwendung zum ueberziehen von arzneimittel DD237611A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3438291A DE3438291A1 (de) 1984-10-19 1984-10-19 Verfahren zur herstellung einer waessrigen ueberzugsmitteldispersion und ihre verwendung zum ueberziehen von arzneimitteln

Publications (1)

Publication Number Publication Date
DD237611A5 true DD237611A5 (de) 1986-07-23

Family

ID=6248261

Family Applications (1)

Application Number Title Priority Date Filing Date
DD85281842A DD237611A5 (de) 1984-10-19 1985-10-17 Verfahren zur herstellung einer waessrigen ueberzugsmitteldispersion und ihre verwendung zum ueberziehen von arzneimittel

Country Status (8)

Country Link
US (1) US4737357A (cs)
EP (1) EP0181515B1 (cs)
JP (1) JPH0764756B2 (cs)
AT (1) ATE56143T1 (cs)
CS (1) CS262424B2 (cs)
DD (1) DD237611A5 (cs)
DE (2) DE3438291A1 (cs)
HU (1) HU195109B (cs)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1322806C (en) * 1986-11-11 1993-10-05 Noboru Yamaguchi Aqueous dispersion of cationic polymer
DE3773189D1 (de) * 1987-03-25 1991-10-24 Sekisui Chemical Co Ltd Harz zur anwendung bei magnetischen aufzeichnungstraegern und verfahren zu seiner herstellung.
DE3723668A1 (de) * 1987-07-17 1989-01-26 Roehm Gmbh Staubarmes spruehgetrocknetes emulsionspolymerisat und verfahren zu seiner herstellung und anwendung
DE3920082A1 (de) * 1989-06-20 1991-03-07 Roehm Gmbh Filmbildendes waessriges ueberzugsmittel fuer feste arzneimittel, verfahren zu seiner herstellung und verwendung
US5028676A (en) * 1989-06-26 1991-07-02 Sekisui Kagaku Kogyo Kabushiki Kaisha Resin for magnetic recording media from vinyl chloride with quanternary and phosphoric monomers
JPH0674206B2 (ja) * 1989-12-28 1994-09-21 田辺製薬株式会社 放出制御型製剤およびその製法
DE4133192A1 (de) * 1991-10-07 1993-04-08 Basf Ag Verfahren zum ueberziehen von arzneiformen
DE4220782A1 (de) * 1992-06-25 1994-01-05 Basf Ag Verfahren zur Herstellung von festen pharmazeutischen Retardformen
HU213407B (en) * 1993-12-09 1997-06-30 Egyt Gyogyszervegyeszeti Gyar Process for producing tablet with diffusive-osmotic release
DE4405156C1 (de) * 1994-02-18 1995-10-26 Univ Karlsruhe Verfahren zur Herstellung beschichteter polymerer Mikropartikel
US6165988A (en) * 1995-02-10 2000-12-26 Christian Noe Medicament in particulate form
DE19653605C2 (de) * 1996-12-20 2002-11-28 Roehm Gmbh Haft- und Bindemittel für dermale oder transdermale Therapiesysteme und dessen Verwendung zur Herstellung eines transdermalen Therapiesystems
DE19918435A1 (de) * 1998-07-23 2000-01-27 Roehm Gmbh Überzugs- und Bindemittel für orale oder dermale Arzneiformen
CA2383212C (en) * 1999-09-02 2008-11-25 Nostrum Pharmaceuticals, Inc. Controlled release oral dosage suitable for oral administration
US20050175687A1 (en) * 2001-01-30 2005-08-11 Mcallister Stephen M. Pharmaceutical formulations
GB0102342D0 (en) * 2001-01-30 2001-03-14 Smithkline Beecham Plc Pharmaceutical formulation
US7883721B2 (en) 2001-01-30 2011-02-08 Smithkline Beecham Limited Pharmaceutical formulation
DE10104880A1 (de) * 2001-01-31 2002-08-08 Roehm Gmbh Multipartikuläre Arzneiform, enthaltend mindestens zwei unterschiedlich überzogene Pelletformen
DE10127134A1 (de) * 2001-06-05 2002-12-12 Roehm Gmbh verfahren zur Herstellung von Formkörpern aus (Meth)acrylat-Copolymeren mittels Spritzguß
US7772138B2 (en) 2002-05-21 2010-08-10 Kimberly-Clark Worldwide, Inc. Ion sensitive, water-dispersible polymers, a method of making same and items using same
US6960371B2 (en) * 2002-09-20 2005-11-01 Kimberly-Clark Worldwide, Inc. Water-dispersible, cationic polymers, a method of making same and items using same
US7101456B2 (en) * 2002-09-20 2006-09-05 Kimberly-Clark Worldwide, Inc. Ion triggerable, cationic polymers, a method of making same and items using same
US7141519B2 (en) * 2002-09-20 2006-11-28 Kimberly-Clark Worldwide, Inc. Ion triggerable, cationic polymers, a method of making same and items using same
US6994865B2 (en) * 2002-09-20 2006-02-07 Kimberly-Clark Worldwide, Inc. Ion triggerable, cationic polymers, a method of making same and items using same
US20040058600A1 (en) * 2002-09-20 2004-03-25 Bunyard W. Clayton Water-dispersible, cationic polymers, a method of making same and items using same
US7157389B2 (en) * 2002-09-20 2007-01-02 Kimberly-Clark Worldwide, Inc. Ion triggerable, cationic polymers, a method of making same and items using same
DE10250543A1 (de) * 2002-10-29 2004-05-19 Röhm GmbH & Co. KG Mehrschichtige Arzneiform
US7244764B2 (en) * 2003-06-23 2007-07-17 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
US20070010573A1 (en) * 2003-06-23 2007-01-11 Xianqi Kong Methods and compositions for treating amyloid-related diseases
US7414076B2 (en) * 2003-06-23 2008-08-19 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
TW200526274A (en) 2003-07-21 2005-08-16 Smithkline Beecham Plc Pharmaceutical formulations
WO2005020961A1 (en) * 2003-08-28 2005-03-10 Sandoz Ag Pharmaceutical composition comprising anticonvulsant with taste mask coating
GB0403247D0 (en) 2004-02-13 2004-03-17 Tillotts Pharma Ag A pharmaceutical composition
TW201240679A (en) * 2004-03-12 2012-10-16 Capsugel Belgium Nv Pharmaceutical formulations
US20060183800A1 (en) * 2004-11-12 2006-08-17 Xianqi Kong Methods and fluorinated compositions for treating amyloid-related diseases
JP2008520647A (ja) * 2004-11-16 2008-06-19 ニューロケム （インターナショナル） リミテッド Ｃｎｓおよびアミロイド関連疾患治療のための化合物
CN101128421A (zh) 2004-12-22 2008-02-20 神经化学（国际）有限公司 治疗淀粉样相关疾病用的方法与组合物
KR101443573B1 (ko) 2006-10-12 2014-11-03 비에이치아이 리미티드 파트너쉽 3-아미노-1-프로판설폰산을 전달하기 위한 방법, 화합물, 조성물 및 비히클
DE102007009242A1 (de) 2007-02-22 2008-09-18 Evonik Röhm Gmbh Pellets mit magensaftresistenter Wirkstoff-Matix
DE102007009243A1 (de) 2007-02-22 2008-09-18 Evonik Röhm Gmbh Pellets mit einer Wirkstoff-Matrix und einem Polymerüberzug, sowie ein Verfahren zur Herstellung der Pellets
JP2012502883A (ja) * 2008-06-13 2012-02-02 グラクソ グループ リミテッド 医薬製剤
KR20120110098A (ko) 2009-11-16 2012-10-09 에보니크 룀 게엠베하 고형 (메트)아크릴레이트 공중합체를 분산제에 의해 분산된 형태로 전환시키는 방법
SI2627684T1 (sl) * 2010-10-13 2014-10-30 Evonik Roehm Gmbh Postopek priprave kopolimera met(akrilata), ki vsebuje kvaternarne amonijeve skupine s polimerizacijo prostih radikalov v raztopini
HK1207823A1 (en) 2012-09-28 2016-02-12 赢创工业集团股份有限公司 Process for preparing aqueous dispersions
WO2014108192A1 (en) 2013-01-10 2014-07-17 Evonik Industries Ag Electronic device unit being equipped on the outside with a coating layer comprising a cationic (meth)acrylate copolymer
PL3681918T3 (pl) 2017-09-14 2022-04-19 Evonik Operations Gmbh Polimer i postać dawkowania o właściwościach przedłużonego uwalniania i odporności na wpływ etanolu
CN112469399A (zh) 2018-03-09 2021-03-09 赢创运营有限公司 耐受乙醇影响的聚合物混合物

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3287305A (en) * 1953-10-30 1966-11-22 Ciba Ltd Cationactive dispersions of finely divided water-insoluble cationactive polymers containing quaternary ammonium groups
AT270071B (de) 1966-08-12 1969-04-10 Roehm & Haas Gmbh Dragierlack für Arzneiformen
US4077930A (en) * 1974-07-16 1978-03-07 Calgon Corporation Self-inverting emulsions of dialkyldiallyl ammonium chloride polymers and copolymers
JPS53149292A (en) * 1977-05-31 1978-12-26 Sumitomo Chem Co Ltd High-polymer ampholyte, its production and paper-strengthening agent and high-polymer coagulant containing the same as major ingredient
US4305860A (en) * 1980-08-21 1981-12-15 National Starch And Chemical Corporation Stable, pumpable, solvent-free colloidal polyampholyte latices, their preparation and use in paper
DE3106449A1 (de) * 1981-02-20 1982-09-09 Röhm GmbH, 6100 Darmstadt "in magensaft loesliche oder quellbare ueberzugsmasse und ihre verwendung in einem verfahren zum ueberziehen von arzneiformen"
DE3208791A1 (de) * 1982-03-11 1983-09-22 Röhm GmbH, 6100 Darmstadt Verfahren zum ueberziehen von arzneiformen mittes eines in wasser dispergierten ueberzugsmittels
US4444954A (en) * 1982-09-30 1984-04-24 The Sherwin-Williams Company Water reducible quaternary ammonium salt containing polymers
US4444955A (en) * 1982-09-30 1984-04-24 The Sherwin-Williams Company Water reducible quaternary ammonium salt containing polymers
US4548981A (en) * 1983-07-01 1985-10-22 Polaroid Corporation Compositions and articles containing polymeric vinyl aromatic aminimides
US4617362A (en) * 1984-12-31 1986-10-14 Allied Corporation Inverse emulsion polymers with improved incorporation of diallyldimethylammonium chloride

Also Published As

Publication number Publication date
DE3579558D1 (de) 1990-10-11
JPH0764756B2 (ja) 1995-07-12
US4737357A (en) 1988-04-12
EP0181515B1 (de) 1990-09-05
CS262424B2 (en) 1989-03-14
DE3438291A1 (de) 1986-04-24
CS732085A2 (en) 1988-07-15
ATE56143T1 (de) 1990-09-15
EP0181515A3 (en) 1987-08-19
JPS61100527A (ja) 1986-05-19
HU195109B (en) 1988-04-28
HUT38535A (en) 1986-06-30
EP0181515A2 (de) 1986-05-21

Similar Documents

Publication Publication Date Title
EP0181515B1 (de) Verfahren zur Herstellung einer wässrigen Überzugsmitteldispersion und ihre Verwendung zum Überziehen von Arzneimitteln
EP0164669B1 (de) Verfahren zum Überziehen von Arzneiformen
DE69105222T2 (de) Auf quervernetzte Polymere aufgebrachte und mit Polymerfilmen beschichtete therapeutische Zusammensetzungen mit kontrollierter Freisetzung von Medikamenten und deren Herstellungsverfahren.
EP0088951B1 (de) Verfahren zum Überziehen von Arzneiformen mittels eines in Wasser dispergierten Überzugsmittels
DE69937650T2 (de) Bupropionhydrochlorid enthaltende Tabletten mit gesteuerter Wirkstoffabgabe
EP0058765B1 (de) In Magensaft lösliche oder quellbare Überzugsmasse und ihre Verwendung in einem Verfahren zum Überziehen von Arzneiformen
EP0368216B1 (de) Feste pharmazeutische Retardform
DE3877764T2 (de) Ein freifliessendes granulat, enthaltend ibuprofen und ein herstellunsgverfahren.
EP0545209B1 (de) Redispergierbares Dispersionspulver aus N-Vinylpyrrolidon-Vinylacetat-Copolymerisat, dessen Herstellung und Verwendung
DE69816951T2 (de) Zubereitung enthaltend Cefaclor oder Cephalexin mit modifizierter Freisetzungsmatrix
DE3915150C2 (de) Lang-wirkendes Diclofenac-Natrium-Präparat
CH650923A5 (de) Verfahren zur herstellung eines ueberzugsmittels fuer arzneiformen.
DE2031871A1 (de) Überzugsmasse für Arzneiformen
EP0485840B1 (de) Orale Arzneiform und Überzugsmittel, enthaltend ein im Colon abbaubares Polysaccharid
EP1572162A1 (de) Verfahren zur herstellung von überzogenen arzneiformen und nahrungsergänzungsmitteln mit konzentrationsgradienten im überzug
DE2741755C2 (de) Überzugsmassen auf Polymerbasis für biologisch aktive Präparate, Verfahren zu ihrer Herstellung sowie mit diesen Überzugsmassen überzogene biologisch aktive Präparate und Verfahren zur Herstellung derselben
DE2721603A1 (de) Beschichtete koernchen aus alkalimetallsalzen der polyacrylsaeure und verfahren zu ihrer herstellung
EP1478344A2 (de) Schmelzextrusion von wirkstoffsalzen
EP0208213B1 (de) Arzneimittelumhüllung
DE20320377U1 (de) Neuer Filmüberzug
DE1925919C3 (de) Tablette für die gleichmäßige Freisetzung eines Arzneimittels
DE4133192A1 (de) Verfahren zum ueberziehen von arzneiformen
DE3883227T2 (de) Feste arzneiform mit verzögerter freisetzung und methode für deren herstellung.
DD233940A5 (de) Verfahren zum ueberziehen von arzneiformen
DE10048888A1 (de) Wässrige Polymerdispersion

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee